Target
von Hippel-Lindau disease tumor suppressor
Ligand
BDBM454881
Substrate
n/a
Meas. Tech.
Fluorescence Polarization Assay (10% DMSO)
IC50
465±n/a nM
Citation
 Crew, APCrews, CMChen, XDong, HFerraro, CQian, YSiu, KWang, JJin, MBerlin, MZimmermann, KSnyder, L Compounds and methods for the enhanced degradation of targeted proteins US Patent  US10730870 Publication Date 8/4/2020 
Target
Name:
von Hippel-Lindau disease tumor suppressor
Synonyms:
Protein G7 | VHL | VHL_HUMAN | Von Hippel-Lindau disease tumor suppressor | Von Hippel-Lindau disease tumor suppressor protein (VBC) | pVHL
Type:
Protein
Mol. Mass.:
24136.87
Organism:
Homo sapiens (Human)
Description:
P40337
Residue:
213
Sequence:
MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD
  
Inhibitor
Name:
BDBM454881
Synonyms:
US10730870, Example 44 | US11512083, Example 44
Type:
Small organic molecule
Emp. Form.:
C31H38N4O4S
Mol. Mass.:
562.723
SMILES:
Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCc2ccccc2)C(C)(C)C)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: